December 4, 2019
The Investing News Network profiles the five top biotech news stories of the year as decided by our readers.
June 6, 2019
INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...
June 5, 2019
Dan Legault, CEO of Antibe Therapeutics, told INN that the company's second candidate, ATB-352, will be used to treat post-operative...
May 16, 2019
BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...
May 9, 2019
In this BBHIC interview, Antibe Therapeutics CEO Dan Legault says his company will be "Phase 3 ready" by the summer.
May 1, 2019
The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.
April 24, 2019
The Investing News Network spoke with the CEO of Antibe Therapeutics about its lead drug candidate and how it is...